Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycosylation Analysis of Anti-DNA Auto-antibodies as Biomarker in the Follow up of Patients With Lupus Erythematosus Disseminated (GALA)

NCT05394922 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05394922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05394922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycosylation Analysis of Anti-DNA Auto-antibodies as Biomarker in the Follow up of Patients With Lupus Erythematosus Disseminated (GALA)
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
August 23, 2022
Completion date
February 22, 2027
Enrollment
140 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, chronic disease, lupus erythematosus disseminatus